rs527236086
Positions:
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PP3PP5_Very_Strong
The NM_014249.4(NR2E3):c.364C>T(p.Arg122Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000226 in 1,550,930 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000023 ( 0 hom. )
Consequence
NR2E3
NM_014249.4 missense
NM_014249.4 missense
Scores
8
5
1
Clinical Significance
Conservation
PhyloP100: 4.87
Genes affected
NR2E3 (HGNC:7974): (nuclear receptor subfamily 2 group E member 3) This protein is part of a large family of nuclear receptor transcription factors involved in signaling pathways. Nuclear receptors have been shown to regulate pathways involved in embryonic development, as well as in maintenance of proper cell function in adults. Members of this family are characterized by discrete domains that function in DNA and ligand binding. This gene encodes a retinal nuclear receptor that is a ligand-dependent transcription factor. Defects in this gene are a cause of enhanced S cone syndrome. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.836
PP5
Variant 15-71811969-C-T is Pathogenic according to our data. Variant chr15-71811969-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 143147.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-71811969-C-T is described in Lovd as [Likely_pathogenic]. Variant chr15-71811969-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR2E3 | NM_014249.4 | c.364C>T | p.Arg122Cys | missense_variant | 4/8 | ENST00000617575.5 | NP_055064.1 | |
NR2E3 | NM_016346.4 | c.364C>T | p.Arg122Cys | missense_variant | 4/7 | NP_057430.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR2E3 | ENST00000617575.5 | c.364C>T | p.Arg122Cys | missense_variant | 4/8 | 1 | NM_014249.4 | ENSP00000482504 | P1 | |
NR2E3 | ENST00000621098.1 | c.364C>T | p.Arg122Cys | missense_variant | 4/7 | 1 | ENSP00000479962 | |||
NR2E3 | ENST00000621736.4 | c.100C>T | p.Arg34Cys | missense_variant | 6/10 | 2 | ENSP00000479254 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152200
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000260 AC: 4AN: 153982Hom.: 0 AF XY: 0.0000366 AC XY: 3AN XY: 81994
GnomAD3 exomes
AF:
AC:
4
AN:
153982
Hom.:
AF XY:
AC XY:
3
AN XY:
81994
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000229 AC: 32AN: 1398730Hom.: 0 Cov.: 33 AF XY: 0.0000217 AC XY: 15AN XY: 690020
GnomAD4 exome
AF:
AC:
32
AN:
1398730
Hom.:
Cov.:
33
AF XY:
AC XY:
15
AN XY:
690020
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152200Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74348
GnomAD4 genome
AF:
AC:
3
AN:
152200
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74348
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Enhanced S-cone syndrome Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 26, 2024 | - - |
Uncertain significance, flagged submission | clinical testing | Natera, Inc. | Apr 16, 2020 | - - |
NR2E3-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 07, 2024 | The NR2E3 c.364C>T variant is predicted to result in the amino acid substitution p.Arg122Cys. This variant has been reported in the homozygous state in two siblings with retinitis pigmentosa from a consanguineous family (Family RP670, Bocquet et al. 2013. PubMed ID: 24339724). This variant has also been reported in the homozygous and compound heterozygous states in additional unrelated individuals with retinal dystrophies (Murro et al. 2018. PubMed ID: 30324420; Patient K6189, Table S6, Oishi et al. 2014. PubMed ID: 25324289; Table S2, Zampaglione et al. 2020. PubMed ID: 32037395). This variant is reported in 0.0081% of alleles in individuals of East Asian descent in gnomAD. Given the evidence, we interpret this variant as likely pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 122 of the NR2E3 protein (p.Arg122Cys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with clinical features of autosomal recessive NR2E3-related conditions (PMID: 24339724, 30324420, 32037395; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 143147). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NR2E3 protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. - |
Retinal dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | May 19, 2019 | - - |
Retinitis pigmentosa Pathogenic:1
Likely pathogenic, no assertion criteria provided | literature only | Department of Ophthalmology and Visual Sciences Kyoto University | - | - - |
Enhanced S-cone syndrome;C1970163:Retinitis pigmentosa 37 Uncertain:1
Uncertain significance, flagged submission | clinical testing | Counsyl | Nov 01, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Benign
DEOGEN2
Pathogenic
.;D;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;M;M
PrimateAI
Uncertain
T
Sift4G
Pathogenic
D;D;D
Polyphen
1.0
.;D;.
Vest4
MutPred
0.53
.;Loss of MoRF binding (P = 0.0371);Loss of MoRF binding (P = 0.0371);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at